ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Davis Select US Equity

Davis Select US Equity (DUSA)

45,44
-0,14
(-0,31%)
Fermé 02 Février 10:00PM
45,44
0,00
(0,00%)
Après les heures de négociation: 10:25PM

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
45,44
Prix Achat
-
Prix Vente
-
Volume échangé
53 568
45,39 Fourchette du Jour 45,91
35,81 Plage de 52 semaines 45,78
Clôture Veille
45,58
Ouverture
45,75
Dernière Transaction
270
@
45.44
Dernière heure de transaction
Volume moyen (3 m)
46 955
Volume financier
US$ 2 447 649
VWAP
45,6924

DUSA Dernières nouvelles

DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Ca

WILMINGTON, Mass., Feb. 26 /PRNewswire/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its 2009 corporate highlights and year end financial results press release will be issued...

DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

WILMINGTON, Mass., Feb. 2 PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (NASDAQ:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its...

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...

DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

Q3 Domestic PDT revenues up 32% year over year; Q3 Non-GAAP loss improves 86% year over year to ($0.2) million WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.®...

DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units

WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that global sales...

DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America

Second Consecutive Year DUSA Has Been Recognized WILMINGTON, Mass., Oct. 21 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R) (NASDAQ:DUSA), a specialty pharmaceutical company focused on...

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

WILMINGTON, Mass., Sept. 2 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA), a dermatology company that is developing and marketing Levulan Photodynamic Therapy (PDT) and...

DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results

Q2 Domestic PDT revenues up 24% year over year; Kerastick margins reach a record high of 85% WILMINGTON, Mass., Aug. 11 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a...

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA) announces that its corporate highlights and second quarter financial results press release will...

Amex to Trade Options on Nine Securities

Amex to Trade Options on Nine Securities NEW YORK, March 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, March 9, 2004, on the underlying...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.641.4285714285744.845.7844.494499745.30019472SP
43.157.4485694017542.2945.7842.0077825534844.05074325SP
121.272.8752546977644.1745.7841.774695543.88117218SP
263.979.5731854352541.4745.7837.53290042.64480377SP
528.9124.390911579536.5345.7835.812981641.27537386SP
15611.8635.318642048833.5845.7824.672654434.1386942SP
26012.7238.875305623532.7245.7824.672438334.26887988SP
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock